行情

ENDP

ENDP

远藤国际
NASDAQ

实时行情|Nasdaq Last Sale

4.204
-0.086
-2.01%
交易中 12:53 11/14 EST
开盘
4.290
昨收
4.290
最高
4.410
最低
4.150
成交量
288.93万
成交额
--
52周最高
13.64
52周最低
1.970
市值
9.53亿
市盈率(TTM)
-2.2964
分时
5日
1月
3月
1年
5年

分析师评级

14位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ENDP 新闻

  • Endo Int'l. Shares Rebound From Session Low, Still Down 0.4% For Session; Hearing Co. Won Ruling to Block Generic form Of Adrenalin
  • Benzinga.2小时前
  • BioDelivery (BDSI) Stock Up on Q3 Earnings Beat & Raised View
  • Zacks.2小时前
  • NY opioid trial pushed back three months
  • Seeking Alpha - Article.21小时前
  • Miller Value Partners Deep Value Strategies Q3 2019 Letter
  • Seeking Alpha - Article.3天前

更多

所属板块

制药
-0.65%
制药与医学研究
-0.54%

热门股票

名称
价格
涨跌幅

ENDP 简况

Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.
展开

Webull提供Endo International PLC的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。